CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Metro Vaartha dated 20th December 2022. Metro Vaartha.
![[img]](https://eprints.cmfri.org.in/style/images/fileicons/text.png) |
Text
Metro Vaartha_20-12-2022.pdf Download (79kB) |
Official URL: https://www.english.metrovaartha.com/news/80347/cm...
Abstract
The Central Marine Fisheries Research Institute (CMFRI) has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD). A Memorandum of Understanding (MoU) was inked with Emineotech, a private limited company dealing with health products, for commercial production and marketing of the product.
| Item Type: | Article |
|---|---|
| Subjects: | CMFRI News Clippings |
| Divisions: | CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division |
| Depositing User: | Mr. Augustine Sipson N A |
| Date Deposited: | 28 Dec 2022 07:08 |
| Last Modified: | 28 Dec 2022 07:08 |
| URI: | http://eprints.cmfri.org.in/id/eprint/16560 |
Actions (login required)
 |
View Item |
